Acute pancreatitis following brentuximab vedotin therapy for refractory Hodgkin lymphoma: a case report.

Silvana Urru, Elisabetta Mariotti, Paolo Carta, Maurizio Marcias, Roberta Murru, Paolo Sanna, Emanuele Angelucci

Drugs in R&D - 2014

Références BibTex

@Article{UMCMMSA14,
  author       = {Urru, S. and Mariotti, E. and Carta, P. and Marcias, M. and Murru, R. and Sanna, P. and Angelucci, E.},
  title        = {Acute pancreatitis following brentuximab vedotin therapy for refractory Hodgkin lymphoma: a case report.},
  journal      = {Drugs in R\&D},
  year         = {2014},
  keywords     = {pancreatitis, Hodgkin Lymphoma, Brentuximab, pharmacovigilance},
  doi          = {10.1007/s40268-014-0036-x.},
  url          = {https://publications.crs4.it/pubdocs/2014/UMCMMSA14},
}

Autres publications dans la base

» Silvana Urru
» Roberta Murru
» Emanuele Angelucci